Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tarasiuk

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Biochemistry|March 1, 1992
Kinetic parameters for the uptake of anthracycline by drug-resistant and drug-sensitive K562 cellsJ Tarasiuk, A Garnier-Suillerot
Biochemical Pharmacology|June 23, 1992
Thermodynamics of the anthracycline-nuclei interactions in drug-resistant and drug-sensitive K562 cellsJ Tarasiuk, A Garnier-Suillerot
Acta Biochimica Polonica|January 1, 1990
Low stimulation of NADH oxidation and oxygen consumption by 5-iminodaunorubicin and its derivativesJ Tarasiuk, B Stefańska, E Borowski
Biochemical Pharmacology|May 1, 1990
Enzymatic studies of the effect of Cu (II) on oxygen radical production stimulated by daunorubicin and ametantroneJ Tarasiuk, P Kolodziejczyk, E Borowski
Anti-Cancer Drug Design|April 1, 1996
The direct reduction of cytochrome c by some anthraquinone antitumor compoundsJ Tarasiuk, B Stefanska, E Borowski
Biochemical Pharmacology|July 15, 1989
Lack of competition between cytochrome c and anthraquinone type drugs for the reductive sites of NADH dehydrogenaseJ Tarasiuk, A Garnier-Suillerot, E Borowski
Biochemical Pharmacology|May 5, 1993
Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukaemic K562 cellsJ Tarasiuk, J Foucrier, A Garnier-Suillerot
Chemico-Biological Interactions|September 23, 1998
Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloidsE Pereira, J Tarasiuk, A Garnier-Suillerot
Anti-Cancer Drug Design|March 1, 1988
An alternative concept for the molecular nature of the peroxidating ability of anthracycline anti-tumor antibiotics and anthracenodionesA Tempczyk, J Tarasiuk, T Ossowski, et al.
Anti-Cancer Drug Design|August 1, 1992
The essential role of anthraquinones as substrates for NADH dehydrogenase in their redox cycling activityJ Tarasiuk, A Garnier-Suillerot, B Stefańska, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Biochemistry|March 1, 1992
Kinetic parameters for the uptake of anthracycline by drug-resistant and drug-sensitive K562 cellsJ Tarasiuk, A Garnier-Suillerot
Biochemical Pharmacology|June 23, 1992
Thermodynamics of the anthracycline-nuclei interactions in drug-resistant and drug-sensitive K562 cellsJ Tarasiuk, A Garnier-Suillerot
Acta Biochimica Polonica|January 1, 1990
Low stimulation of NADH oxidation and oxygen consumption by 5-iminodaunorubicin and its derivativesJ Tarasiuk, B Stefańska, E Borowski
Biochemical Pharmacology|May 1, 1990
Enzymatic studies of the effect of Cu (II) on oxygen radical production stimulated by daunorubicin and ametantroneJ Tarasiuk, P Kolodziejczyk, E Borowski
Anti-Cancer Drug Design|April 1, 1996
The direct reduction of cytochrome c by some anthraquinone antitumor compoundsJ Tarasiuk, B Stefanska, E Borowski
Biochemical Pharmacology|July 15, 1989
Lack of competition between cytochrome c and anthraquinone type drugs for the reductive sites of NADH dehydrogenaseJ Tarasiuk, A Garnier-Suillerot, E Borowski
Biochemical Pharmacology|May 5, 1993
Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukaemic K562 cellsJ Tarasiuk, J Foucrier, A Garnier-Suillerot
Chemico-Biological Interactions|September 23, 1998
Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloidsE Pereira, J Tarasiuk, A Garnier-Suillerot
Anti-Cancer Drug Design|March 1, 1988
An alternative concept for the molecular nature of the peroxidating ability of anthracycline anti-tumor antibiotics and anthracenodionesA Tempczyk, J Tarasiuk, T Ossowski, et al.
Anti-Cancer Drug Design|August 1, 1992
The essential role of anthraquinones as substrates for NADH dehydrogenase in their redox cycling activityJ Tarasiuk, A Garnier-Suillerot, B Stefańska, et al.
Pageof 3